1. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Off. J. Eur. Union 28 November 2001, L 311
2. Rovira, J., Espín, J., García, L., Olry de Labry, A.: The Impact of Biosimilars’ Entry in the EU Market. Andalusian School of Public Health, Granada (2011)
3. Borget, I., Grivel, T.: Biosimilaires et facteurs medico-economiques. Bull. Cancer 97(5), 589–595 (2010)
4. Grabowski, H., Long, G., Mortimer, R.: Implementation of the biosimilar pathway: economic and policy issues. Seton Hall Law Rev. 41(2), 511–557 (2011)
5. Moran, N.: Fractured European market undermines biosimilar launches. Nat. Biotechnol. 26(1), 5–6 (2008)